![Takashi Kishimoto](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Takashi Kei Kishimoto worked as a Senior Director-Inflammation Research at Millennium Pharmaceuticals, Inc. from 1999 to 2006.
He then worked as an Associate Director-Research at Boehringer Ingelheim Corp.
before becoming the Vice President-Discovery Research at Momenta Pharmaceuticals, Inc. from 2006 to 2011.
He then became the Chief Scientific Officer at Selecta Biosciences, Inc. in 2011, where he worked until 2023.
He also worked as a Vice President-Research at Momenta Corp.
Dr. Kishimoto holds a doctorate degree from Harvard University and an undergraduate degree from New College of Florida.
Eerdere bekende functies van Takashi Kishimoto
| Bedrijven | Functie | Einde |
|---|---|---|
| CARTESIAN THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 13-11-2023 |
| MOMENTA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01-06-2011 |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Corporate Officer/Principal | 01-01-2006 |
Momenta Corp. | Hoofd Techniek/Wetenschap/O&O | - |
Boehringer Ingelheim Corp.
 Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets health care products | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Takashi Kishimoto
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
66
Eerstegraads connecties
7
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 7 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
Momenta Pharmaceuticals, Inc.
 Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that discovers and develops novel biologic therapies for the treatment of rare immune-mediated diseases | Health Technology |
Selecta Biosciences, Inc.
 Selecta Biosciences, Inc. BiotechnologyHealth Technology Develops targeted immunotherapies and vaccines to treat and prevent diseases | Health Technology |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New College of Florida
 New College of Florida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boehringer Ingelheim Corp.
Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets health care products | Health Technology |
Momenta Corp. |
Kies MarketScreener 
